Inventor · disambiguated record
Klaus Büttner
Also filed as: BUETTNER KLAUS · BUTTNER KLAUS
23 granted patents·2 pending applications·1,635 citations·filing 1997–2007
98Inventor score
Technology areasA61P
Top patents by PatentIndex Score
25 records- 0198US6037323AApolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN LOUIS·Filed 1997·Granted Mar 14, 2000·298 cites·54 claims
- 0297US6046166AApolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN LOUIS·Filed 1997·Granted Apr 4, 2000·192 cites·49 claims
- 0396US6376464B1Lipid complexes of APO A-1 agonist compoundsDASSEUX JEAN-LOUIS·Filed 1999·Granted Apr 23, 2002·116 cites·21 claims
- 0496US6004925AApolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX J L·Filed 1997·Granted Dec 21, 1999·265 cites·58 claims
- 0595US6734169B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN LOUIS·Filed 2001·Granted May 11, 2004·68 cites·27 claims
- 0694US6602854B1Branched multimeric Apo A-I agonist compoundsFiled 1999·Granted Aug 5, 2003·79 cites·38 claims
- 0793US6753313B1Multimeric Apoa-I agonist compoundsFiled 1999·Granted Jun 22, 2004·73 cites·48 claims
- 0893US6265377B1Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 1999·Granted Jul 24, 2001·83 cites·48 claims
- 0992US6573239B1Apolipoprotein A-I agonist compoundsFiled 1999·Granted Jun 3, 2003·62 cites·34 claims
- 1091US6844327B2Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 2002·Granted Jan 18, 2005·28 cites·23 claims
- 1191US6630450B1Method of treating dyslipidemiaFiled 1999·Granted Oct 7, 2003·58 cites·36 claims
- 1291US6329341B1Method of treating septic shockESPERION THERAPEUTICS INC·Filed 1999·Granted Dec 11, 2001·61 cites·21 claims
- 1390US6716816B1Multimeric Apo A-I agonist compoundsFiled 1999·Granted Apr 6, 2004·52 cites·58 claims
- 1489US7566695B2Multimeric apoprotein agonistsPFIZER·Filed 2006·Granted Jul 28, 2009·9 cites·8 claims
- 1589US6518412B1Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 1997·Granted Feb 11, 2003·64 cites·9 claims
- 1688US7189689B2Apolipoprotein A-L agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2002·Granted Mar 13, 2007·17 cites·19 claims
- 1787US7211565B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2004·Granted May 1, 2007·19 cites·30 claims
- 1886US7312190B2Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2004·Granted Dec 25, 2007·13 cites·11 claims
- 1985US7307058B2Multimeric Apo A-I agonist compoundsDASSEUX JEAN-LOUIS·Filed 2003·Granted Dec 11, 2007·11 cites·23 claims
- 2085US7250407B2Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disordersPFIZER·Filed 2004·Granted Jul 31, 2007·16 cites·14 claims
- 2183US7273848B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2004·Granted Sep 25, 2007·12 cites·23 claims
- 2282US7157425B2Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2002·Granted Jan 2, 2007·12 cites·17 claims
- 2376US6900177B1Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersFiled 1999·Granted May 31, 2005·27 cites·26 claims
- 2462US2008058270A1Apolipoprotein A-I agonists and their use to treat dyslipidemic disordersDASSEUX JEAN-LOUIS·Filed 2007·Application pending·0 cites
- 2562US2008050351A1Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic DisorderPFIZER·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus Büttner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →